ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 75 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,645,000 | -76.4% | 440,801 | -70.4% | 0.03% | -81.6% |
| Q1 2020 | $11,207,000 | -37.7% | 1,488,314 | +13.7% | 0.15% | -8.1% |
| Q4 2019 | $17,993,000 | +81.9% | 1,308,597 | +57.2% | 0.16% | +61.6% |
| Q3 2019 | $9,889,000 | -1.0% | 832,429 | +16.6% | 0.10% | +3.1% |
| Q2 2019 | $9,986,000 | -21.6% | 713,829 | +0.2% | 0.10% | -20.0% |
| Q1 2019 | $12,741,000 | +26.0% | 712,591 | +10.9% | 0.12% | +13.2% |
| Q4 2018 | $10,110,000 | – | 642,741 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
| RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
| Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
| Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
| Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
| Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
| Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |